55 related articles for article (PubMed ID: 2870482)
1. [Peripheral dopaminergic receptor agonists as potential drugs in diseases of the circulatory system].
Kostowski W
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1448-51. PubMed ID: 2870482
[No Abstract] [Full Text] [Related]
2. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
Imperato A; Tanda G; Frau R; Di Chiara G
J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
[TBL] [Abstract][Full Text] [Related]
3. Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach.
Lefebvre RA; Guenaneche F; De Beurme FA
Eur J Pharmacol; 1990 Aug; 185(1):69-79. PubMed ID: 1977599
[TBL] [Abstract][Full Text] [Related]
4. D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients.
Barone P; Braun AR; Chase TN
Clin Neuropharmacol; 1986; 9 Suppl 4():128-30. PubMed ID: 2952266
[No Abstract] [Full Text] [Related]
5. D-1 and D-2 receptor manipulation in Cebus monkeys: implication for extrapyramidal syndromes in humans.
Gerlach J; Casey D; Kistrup K
Clin Neuropharmacol; 1986; 9 Suppl 4():131-3. PubMed ID: 2952267
[No Abstract] [Full Text] [Related]
6. Intracellularly recorded response of rat striatal neurons in vitro to fenoldopam and SKF 38393 following lesions of midbrain dopamine cells.
Twery MJ; Thompson LA; Walters JR
Synapse; 1994 Sep; 18(1):67-78. PubMed ID: 7825125
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
Bijak M; Danek L; Smiałowski A
Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
[TBL] [Abstract][Full Text] [Related]
8. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
Maura G; Giardi A; Raiteri M
J Pharmacol Exp Ther; 1988 Nov; 247(2):680-4. PubMed ID: 2903237
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potentials of centrally acting dopamine and alpha 2-adrenoreceptor agonists.
Goldstein M; Engel J; Lieberman A; Regev I; Bystritsky A; Mino S
J Neural Transm Suppl; 1983; 18():257-63. PubMed ID: 6135744
[TBL] [Abstract][Full Text] [Related]
11. Selective antagonism of renal hemodynamic changes induced by dopamine, DPDA, fenoldopam and quinpirole in the rat.
Rosenkranz RP; McClelland DL
Proc West Pharmacol Soc; 1987; 30():25-36. PubMed ID: 2888129
[No Abstract] [Full Text] [Related]
12. Dopamine and dopamine receptor agonists in cardiovascular therapy.
Murphy MB; Elliott WJ
Crit Care Med; 1990 Jan; 18(1 Pt 2):S14-8. PubMed ID: 1967161
[TBL] [Abstract][Full Text] [Related]
13. Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.
Kaiser C; Dandridge PA; Garvey E; Hahn RA; Sarau HM; Setler PE; Bass LS; Clardy J
J Med Chem; 1982 Jun; 25(6):697-703. PubMed ID: 6980283
[TBL] [Abstract][Full Text] [Related]
14. Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors.
Andén NE; Grabowska-Andén M
Acta Physiol Scand; 1987 Sep; 131(1):157-8. PubMed ID: 2890261
[No Abstract] [Full Text] [Related]
15. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam.
Weinstock J; Ladd DL; Wilson JW; Brush CK; Yim NC; Gallagher G; McCarthy ME; Silvestri J; Sarau HM; Flaim KE
J Med Chem; 1986 Nov; 29(11):2315-25. PubMed ID: 2878077
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.
Pfeiffer FR; Wilson JW; Weinstock J; Kuo GY; Chambers PA; Holden KG; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM
J Med Chem; 1982 Apr; 25(4):352-8. PubMed ID: 7069713
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced field potential changes in dopaminergic target areas after electrical stimulation of the rat mesencephalon.
Dimpfel W
Neuropsychobiology; 1985; 14(1):42-52. PubMed ID: 2999640
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonists, a new perspective in cardiovascular therapy?
Girbes AR; van Veldhuisen DJ; Smit AJ
Neth J Med; 1991 Aug; 39(1-2):65-71. PubMed ID: 1683693
[No Abstract] [Full Text] [Related]
20. Clinical use of dopamine receptor agonists.
Murphy MB
Proc West Pharmacol Soc; 1990; 33():31-5. PubMed ID: 1980363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
